Lisa R Rogers

Summary

Affiliation: University Hospitals Case Medical Center
Country: USA

Publications

  1. doi request reprint Neurologic complications of radiation
    Lisa R Rogers
    University Hospitals Case Medical Center, Cleveland, Ohio 44106, USA
    Continuum (Minneap Minn) 18:343-54. 2012
  2. doi request reprint Cerebrovascular complications in patients with cancer
    Lisa R Rogers
    Department of Neurology, Neuro Oncology Program, University Hospitals Case Medical Center, Neurological Institute, Cleveland, Ohio 44106, USA
    Semin Neurol 30:311-9. 2010
  3. pmc Erlotinib therapy for central nervous system hemangioblastomatosis associated with von Hippel-Lindau disease: a case report
    Lisa R Rogers
    Department of Neurology, Henry Ford Hospital, Detroit, MI, USA
    J Neurooncol 101:307-10. 2011
  4. doi request reprint Morphologic magnetic resonance imaging features of therapy-induced cerebral necrosis
    L R Rogers
    Department of Neurology, Henry Ford Hospital, Detroit, MI, USA
    J Neurooncol 101:25-32. 2011
  5. doi request reprint Prolonged survival after multifocal brain radiation necrosis associated with whole brain radiation for brain metastases: case report
    Mirela Cerghet
    Department of Neurology, Henry Ford Health System, Detroit, MI, USA
    J Neurooncol 90:85-8. 2008
  6. ncbi request reprint Management of stroke in cancer
    Lisa R Rogers
    Department of Neurology, University of Michigan Health System, 1920F Taubman Center, Ann Arbor, MI 48109, USA
    Curr Oncol Rep 10:72-7. 2008
  7. ncbi request reprint Cerebrovascular complications in patients with cancer
    Lisa R Rogers
    Clinical Neuro Oncology Program, Hermelin Brain Tumor Center, Department of Neurosurgery, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202, USA
    Semin Neurol 24:453-60. 2004
  8. ncbi request reprint Results of a phase II trial of the GliaSite radiation therapy system for the treatment of newly diagnosed, resected single brain metastases
    Lisa R Rogers
    Department of Neurology and Neurosurgery, Henry Ford Hospital, Detroit, Michigan 48109 0316, USA
    J Neurosurg 105:375-84. 2006
  9. pmc Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy
    Lisa R Rogers
    Hermelin Brain Tumor Center, Department of Neurosurgery, Henry Ford Hospital, Detroit, MI 48202, USA
    Neuro Oncol 6:63-4. 2004
  10. ncbi request reprint Cerebrovascular complications in cancer patients
    Lisa R Rogers
    Departments of Neurology and Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI 48202, USA
    Neurol Clin 21:167-92. 2003

Detail Information

Publications10

  1. doi request reprint Neurologic complications of radiation
    Lisa R Rogers
    University Hospitals Case Medical Center, Cleveland, Ohio 44106, USA
    Continuum (Minneap Minn) 18:343-54. 2012
    ..Knowledge of the classic clinical signs, imaging features, and time interval from RT will assist the practitioner in establishing the diagnosis and recommending treatment when appropriate...
  2. doi request reprint Cerebrovascular complications in patients with cancer
    Lisa R Rogers
    Department of Neurology, Neuro Oncology Program, University Hospitals Case Medical Center, Neurological Institute, Cleveland, Ohio 44106, USA
    Semin Neurol 30:311-9. 2010
    ..Careful clinical assessment, neuroimaging studies, measurement of coagulation function, and echocardiography are the most useful modalities to identify the cause of stroke...
  3. pmc Erlotinib therapy for central nervous system hemangioblastomatosis associated with von Hippel-Lindau disease: a case report
    Lisa R Rogers
    Department of Neurology, Henry Ford Hospital, Detroit, MI, USA
    J Neurooncol 101:307-10. 2011
    ..The duration of response was 9 months. The median plasma and CSF levels of erlotinib while on treatment were 1146.06 and 247.83 ng/ml, respectively (CSF 21.6% of plasma). Erlotinib may have antitumor activity in CNS HBs...
  4. doi request reprint Morphologic magnetic resonance imaging features of therapy-induced cerebral necrosis
    L R Rogers
    Department of Neurology, Henry Ford Hospital, Detroit, MI, USA
    J Neurooncol 101:25-32. 2011
    ..These findings may be of value in identifying therapy-induced cerebral necrosis in patients treated for a brain tumor...
  5. doi request reprint Prolonged survival after multifocal brain radiation necrosis associated with whole brain radiation for brain metastases: case report
    Mirela Cerghet
    Department of Neurology, Henry Ford Health System, Detroit, MI, USA
    J Neurooncol 90:85-8. 2008
    ..Anticoagulation with warfarin may have had therapeutic benefit. The patient is alive without a neurological deficit 10 years after the diagnosis of radiation necrosis...
  6. ncbi request reprint Management of stroke in cancer
    Lisa R Rogers
    Department of Neurology, University of Michigan Health System, 1920F Taubman Center, Ann Arbor, MI 48109, USA
    Curr Oncol Rep 10:72-7. 2008
    ..A review of the existing literature reveals that improvement in patient quality of life and prevention of further cerebrovascular events can be obtained in some clinical situations...
  7. ncbi request reprint Cerebrovascular complications in patients with cancer
    Lisa R Rogers
    Clinical Neuro Oncology Program, Hermelin Brain Tumor Center, Department of Neurosurgery, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202, USA
    Semin Neurol 24:453-60. 2004
    ..Hemolysis from chemotherapy administration is a rare cause of brain hemorrhage. Neuroimaging studies, measurement of coagulation function, and echocardiography are the must useful modalities to identify the cause of stroke...
  8. ncbi request reprint Results of a phase II trial of the GliaSite radiation therapy system for the treatment of newly diagnosed, resected single brain metastases
    Lisa R Rogers
    Department of Neurology and Neurosurgery, Henry Ford Hospital, Detroit, Michigan 48109 0316, USA
    J Neurosurg 105:375-84. 2006
    ..The primary end point of the study was local tumor control. The secondary end points included patient survival, distant brain recurrence, quality of life, and treatment toxicity...
  9. pmc Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy
    Lisa R Rogers
    Hermelin Brain Tumor Center, Department of Neurosurgery, Henry Ford Hospital, Detroit, MI 48202, USA
    Neuro Oncol 6:63-4. 2004
    ..We report a durable (12-month) response to capecitabine monotherapy, shown clinically, by MRI, and by cerebrospinal fluid analysis, in a patient with leptomeningeal metastasis from breast cancer...
  10. ncbi request reprint Cerebrovascular complications in cancer patients
    Lisa R Rogers
    Departments of Neurology and Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI 48202, USA
    Neurol Clin 21:167-92. 2003
    ..Therapy may ameliorate symptoms or prevent further episodes. The identification of one of these unusual stroke syndromes that leads to the diagnosis of an occult and treatable cancer can be particularly rewarding...